Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus. The YESTONO Study
Background: Effective blood pressure (BP) lowering therapy is regarded as the most important intervention in diabetes mellitus (DM). Nebivolol is commonly used for the treatment of hypertension (AH), but to date there has been no study of its use in a large population of hypertensive patients with t...
Main Authors: | A. C. Schmidt, Ch. Graf, K. Brixius, J. Scholze |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2160 |
Similar Items
-
Blood pressure and hypertension in type 1 diabetes mellitus patients with long duration
by: T. Chalakova, et al.
Published: (2023-09-01) -
Beta-adrenoblockers in arterial hypertension treatment: focus on nebivolol
by: D. Voytsekhovsky, et al.
Published: (2008-08-01) -
Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure
by: Brian L. Stauffer, et al.
Published: (2017-11-01) -
Blood Pressure Target in Type 2 Diabetes Mellitus
by: Hyun-Jin Kim, et al.
Published: (2022-09-01) -
Beta-adrenoblocker nebivolol in the new Russian guidelines on arterial hypertension
by: L. G. Ratova, et al.
Published: (2008-08-01)